Sign Up for The Checkup

Get the latest news and updates from etectRX

[contact-form-7 id="1302" title="Header Newsletter"]

News

Placeholder

Technology You Ingest: Interview with Harry Travis

6/12/2019

Harry Travis, president & CEO of etectRx, interviewed with the Orlando Entrepreneurs podcast to share the company story. Listen here at https://www.orlandoentrepreneurs.org/technology-you-ingest-interview-with-harry-travis/

Read More
Placeholder

etectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System

6/10/2019

GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued...

Read More
Placeholder

Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills

6/6/2019

Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills

Read More
Placeholder

etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities

6/6/2019

Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to...

Read More
Placeholder

etectRx’s Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study

3/4/2019

Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March...

Read More
Placeholder

Digital Pills May Be on the Horizon in Cancer Care

3/1/2019

CEO of etectRx, Harry Travis, spoke with Oncology Live about digital pills, like the ID-Capsule, as a possibility for improving cancer care. Read more at https://www.onclive.com/publications/Oncology-live/2019/vol-20-no-5/digital-pills-may-be-on-the-horizon-in-cancer-care?p=1

Read More
Placeholder

Guardian angel or watchdog? Pills of capecitabine contain sensors

2/15/2019

CEO of etectRx, Harry Travis, spoke with MDedge about the future of digital medicine and how our state-of-the-art ID-Cap system can impact the medical industry. Read more...

Read More
etectRx Officially Moves into the University of Florida’s Innovation Hub

etectRx Officially Moves into the University of Florida’s Innovation Hub

2/26/2018

We are proud to announce that etectRx has officially moved into the UF Innovation Hub’s ultra-modern facilities, providing our team the additional lab and office...

Read More
UF’s Newly Expanded Innovation Hub Welcomes etectRx

UF’s Newly Expanded Innovation Hub Welcomes etectRx

9/18/2017

etectRx™ is committed to advancing digital health through extensive research and innovation. When considering a location for the new office, it was crucial that the facility not...

Read More
Placeholder

etectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System

9/7/2017

GAINESVILLE, Fla. (Sept. 7, 2017) – etectRx™, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has...

Read More
Placeholder

NW Arkansas Technology Summit to feature presentation from Harry Travis

8/30/2017

The theme of the 2017 Northwest Arkansas Technology Summit is Connected Devices, Connected World, which translates into the work that etectRx™ is championing in the medication...

Read More
Placeholder

Harry Travis, CEO of etectRx, to appear on panel at NASP Annual Meeting & Expo

8/30/2017

The National Association of Specialty Pharmacy (NASP) is hosting its fifth annual meeting in Washington, DC, September 18-20, 2o17. etectRx™ is proud that Harry Travis will...

Read More